Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside

Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside

Immune checkpoint inhibitor (ICI)-related inflammatory diseases, including polymyositis (PM) and dermatomyositis (DM), in patients suffering from neoplastic disorders represent a medical challenge. The treatment of these conditions has taken on new urgency due to the successful and broad development...

Full description

Bibliographic Details
Main Authors: Antonio G. Solimando, Lucilla Crudele, Patrizia Leone, Antonella Argentiero, Matteo Guarascio, Nicola Silvestris, Angelo Vacca, Vito Racanelli
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:International Journal of Molecular Sciences
Subjects:
immune checkpoint inhibitors
immune-related adverse events
myositis
dermatomyositis
polymyositis
autoimmunity
Online Access:https://www.mdpi.com/1422-0067/21/9/3054

Internet

https://www.mdpi.com/1422-0067/21/9/3054

Similar Items